CytRx Corporation announced Joel Caldwell tendered his resignation as a Class III director in anticipation of being appointed a Class II director. On May 27, 2022, following Mr. Caldwell's resignation as a Class III director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | +12.32% | +3.33% | +138.46% |
1st Jan change | Capi. | |
---|---|---|
+138.46% | 1.53M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Announces Director Changes